(Q34081656)

30 July 2017

title

Bringing buprenorphine-naloxone detoxification to community treatment providers: the NIDA Clinical Trials Network field experience (English)

1 reference

30 July 2017

14

Theresa Winhusen

0 references

Susan Stine

object named as

Susan Stine

13

0 references

author name string

Leslie Amass

1

1 reference

30 July 2017

Walter Ling

2

1 reference

30 July 2017

Thomas E Freese

3

1 reference

30 July 2017

Chris Reiber

4

1 reference

30 July 2017

Jeffrey J Annon

5

1 reference

30 July 2017

Allan J Cohen

6

1 reference

30 July 2017

Dennis McCarty

7

1 reference

30 July 2017

Malcolm S Reid

8

1 reference

30 July 2017

Lawrence S Brown

9

1 reference

30 July 2017

Cynthia Clark

10

1 reference

30 July 2017

Douglas M Ziedonis

11

1 reference

30 July 2017

Jonathan Krejci

12

1 reference

30 July 2017

Greg Brigham

15

1 reference

30 July 2017

Dean Babcock

16

1 reference

30 July 2017

Joan A Muir

17

1 reference

30 July 2017

Betty J Buchan

18

1 reference

30 July 2017

Terry Horton

19

1 reference

30 July 2017

publication date

1 January 2004

1 reference

American Journal on Addictions

30 July 2017

published in

1 reference

30 July 2017

volume

13 Suppl 1

1 reference

30 July 2017

page(s)

S42-66

1 reference

Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone.

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

The Clinical Opiate Withdrawal Scale (COWS).

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine: how to use it right

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Pharmacokinetics of the combination tablet of buprenorphine and naloxone

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Clinical and pharmacological evaluation of buprenorphine and naloxone combinations: why the 4:1 ratio for treatment?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

From morphine clinics to buprenorphine: regulating opioid agonist treatment of addiction in the United States

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Self-administration of intravenous buprenorphine and the buprenorphine/naloxone combination by recently detoxified heroin abusers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine: blending practice and research

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Effects of buprenorphine/naloxone in opioid-dependent humans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Double-blind randomized trial of buprenorphine and methadone in opiate dependence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine: "field trials" of a new drug

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Thrice-weekly supervised dosing with the combination buprenorphine-naloxone tablet is preferred to daily supervised dosing by opioid-dependent humans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Plasma concentrations of buprenorphine 24 to 72 hours after dosing.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine-related deaths among drug addicts in France: a report on 20 fatalities

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Comparison of buprenorphine and methadone in the treatment of opioid dependence. Swiss multicentre study

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine and naloxone interactions in methadone maintenance patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

The effects of psychosocial services in substance abuse treatment.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Clinical pharmacology of buprenorphine: ceiling effects at high doses

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

The use of the DSM-III-R Checklist for initial diagnostic assessments

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

A controlled comparison of buprenorphine and clonidine for acute detoxification from opioids

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Opiate withdrawal using clonidine. A safe, effective, and rapid nonopiate treatment

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

New data from the Addiction Severity Index. Reliability and validity in three centers

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine: a new maintenance opiate?

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Success and failure at outpatient opioid detoxification. Evaluating the process of clonidine- and methadone-assisted withdrawal

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Clonidine and the treatment of the opiate withdrawal syndrome

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Safety and side-effects of buprenorphine in the clinical management of heroin addiction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

A controlled trial of buprenorphine treatment for opioid dependence

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Human pharmacology and abuse potential of the analgesic buprenorphine: a potential agent for treating narcotic addiction

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine versus methadone maintenance therapy: a randomized double-blind trial with 405 opioid-dependent patients

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

1-year retention and social function after buprenorphine-assisted relapse prevention treatment for heroin dependence in Sweden: a randomised, placebo-controlled trial

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

A new series of 13 buprenorphine-related deaths

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

A randomized controlled trial of buprenorphine in the management of short-term ambulatory heroin withdrawal.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

New federal initiatives to enhance the medical treatment of opioid dependence

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Detoxification of opiate addicts with multiple drug abuse: a comparison of buprenorphine vs. methadone

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Putting drug abuse research to use in real-life settings

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine and addiction: challenges for the pharmacist

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Intravenous buprenorphine self-administration by detoxified heroin abusers

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

A controlled trial of buprenorphine treatment for opium dependence: the first experience from Iran.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Deaths involving buprenorphine: a compendium of French cases

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

A 33-year follow-up of narcotics addicts

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine and naloxone co-administration in opiate-dependent patients stabilized on sublingual buprenorphine

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine: a controlled clinical trial in the treatment of opioid dependence

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine versus methadone maintenance for the treatment of opioid dependence.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine and naloxone combinations: the effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Preliminary assessment of a 10-day rapid detoxification programme using high dosage buprenorphine.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Substitution with buprenorphine in methadone- and morphine sulfate-dependent patients. Preliminary results.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

A randomized trial of buprenorphine maintenance for heroin dependence in a primary care clinic for substance users versus a methadone clinic.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine maintenance treatment of opiate dependence: a multicenter, randomized clinical trial.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Effects of adding behavioral treatment to opioid detoxification with buprenorphine

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Buprenorphine vs methadone maintenance treatment for concurrent opioid dependence and cocaine abuse

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

A controlled trial comparing buprenorphine and methadone maintenance in opioid dependence

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Subjective and physiologic effects of intravenous buprenorphine in humans.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Comparison of buprenorphine and methadone in the treatment of opioid dependence

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Effects of buprenorphine and methadone in methadone-maintained subjects.

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Use of buprenorphine in the treatment of opioid addiction. II. Physiologic and behavioral effects of daily and alternate-day administration and abrupt withdrawal

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1255908

Efficacy of daily and alternate-day dosing regimens with the combination buprenorphine-naloxone tablet

28 October 2018

1 reference

12 December 2020

Lapse, relapse and survival among opiate addicts after treatment. A prospective follow-up study

1 reference

12 December 2020

The feasibility of abrupt methadone-buprenorphine transfer in British opiate addicts in an outpatient setting

1 reference

12 December 2020

A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts

1 reference

12 December 2020

Acute administration of buprenorphine in humans: partial agonist and blockade effects

1 reference

12 December 2020

A preliminary investigation of outcome following gradual or rapid buprenorphine detoxification

1 reference

12 December 2020

Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone

1 reference

12 December 2020

Buprenorphine and naloxone interactions in opiate-dependent volunteers*

1 reference

12 December 2020

The effects of buprenorphine in buprenorphine-maintained volunteers

1 reference

12 December 2020

Six deaths linked to misuse of buprenorphine-benzodiazepine combinations

1 reference

12 December 2020

[Acute poisoning during substitution therapy based on high-dosage buprenorphine. 29 clinical cases--20 fatal cases]

1 reference

12 December 2020

10.1080/10550490490440807

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference